Skip to content

Serotonin: all studies

Page 381 of 401: studies 3,801 to 3,810 of 4,004, newest first. Back to the serotonin overview

Research

Tissue distribution, metabolism and effects of bufotenine administered to rats.

Neuropharmacology July 1, 1995 R W Fuller, H D Snoddy, K W Perry 37 citations

Bufotenine (N, N-dimethyl-5-hydroxytryptamine) is a serotonin analog reported to be hallucinogenic. Bufotenine concentrations were measured by liquid chromatography with electrochemical detection after the s.c. injection of bufotenine (1, 30 or 100 mg/kg) into rats. At 1 hr, bufotenine was high in lung, heart and blood and lower in brain and liver. No N-monomethyl-5-hydroxytryptamine was...

Stress Reduction and Preventing Hypertension: Preliminary Support for a Psychoneuroendocrine Mechanism

The Journal of Alternative and Complementary Medicine June 1, 1995 Kenneth G Walton, Nirmal D. Pugh, Paul Gelderloos et al. 161 citations

Our objective was to identify endocrine-related mechanisms capable of mediating preventive effects of stress reduction in hypertensive heart disease. Since beneficial effects of stress reduction accrue over time, this cross-sectional, descriptive study sought differences between healthy students not practicing a systematic technique for reducing stress (the average stress, or AS, group, n = 33)...

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Psychopharmacology June 1995 A R Green, A J Cross, G M Goodwin

3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") was first synthesised 80 years ago, but has recently received prominence as an illegally synthesised recreational drug of abuse. There is a widely held belief among misusers that it is safe. In the last 2-3 years there have been a number of reports of the drug producing severe acute toxicity and death and there are concerns that it may cause...

Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration.

Brain Research May 1, 1995 S R White, G C Harris, K M Imel et al.

Rats were allowed to self-administer cocaine during a 3-h session for 15 days. One to 11 days after the last cocaine exposure, rats were anesthetized with urethane and effects of microiontophoretically-applied dopamine on glutamate-evoked firing of neurons in the nucleus accumbens and in the caudate/putamen were tested. Dopamine produced a dose-dependent inhibition of glutamate-evoked firing in...

DOI: 10.1016/0006-8993(95)00309-e (opens in new tab) Brain Caudate nucleus Putamen Nucleus accumbens +11

Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines

Journal of Psychopharmacology May 1, 1995 Hugh Series, Marisa Le Masurier, Sarah E. Gartside et al. 13 citations

The amphetamine derivatives p-chloroamphetamine (pCA), 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and D-fenfluramine can, if given repeatedly in high doses to rats, produce a degeneration of serotonergic nerve terminals which we have previously shown to result in a reduction in D-fenfluramine-evoked release of 5-HT in vivo. It is therefore possible that fenfluramine-evoked responses...

Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro.

Clinical and experimental pharmacology & physiology May 1995 C Cerruti, P Sheng, Bruce Ladenheim et al.

1. Inhibitors of nitric oxide (NO) formation or ADP-ribosylation attenuate methamphetamine (METH)- and methylenedioxymetamphetamine (MDMA)-induced neurotoxicity on dopaminergic and serotonergic cells in primary cultures. 2. They also prevent METH-induced reactive gliosis in dopaminergic cultures. 3. Overexpression of superoxide dismutase (SOD) in cells obtained from SOD-transgenic mice also...

Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI.

Pharmacology, Biochemistry, and Behavior April 1995 N A Darmani, C F Gerdes

Previously, we reported that administration of the 5-HT2A/C receptor agonist, DOI [(+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane], can simultaneously produce the head-twitch response (HTR) and the ear-scratch response (ESR) in mice. Our recent studies have indicated that the HTR is a 5-HT2A receptor-mediated phenomenon, whereas the ESR is probably a 5-HT2C receptor-mediated event. The HTR...

Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum.

Psychopharmacology April 1995 J E Sprague, D E Nichols

The effects of the MAO-B inhibitors, L-deprenyl and MDL-72974 on MDMA-induced serotonergic neurotoxicity in rats were examined. MDMA alone produced a significant decrease in the number of 5-HT uptake sites, measured as a decrease in the Bmax for binding of [3H]paroxetine, and in 5-HT and 5-HIAA levels in the striatum. L-Deprenyl and MDL-72974 attenuated this MDMA-induced decrease in...

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine.

Psychopharmacology April 1995 K M Hegadoren, M T Martin-Iverson, G B Baker

Spontaneous behaviours were assessed in freely moving rats after treatment with equimolar doses of drugs that share a basic amphetamine structure. The drugs used included a psychomotor stimulant [(+)-amphetamine (AMPH)], an hallucinogen [para-methoxyamphetamine (PMA)] and the entactogens 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and...

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Psychopharmacology April 1995 V J Watts, C P Lawler, D R Fox et al.

The hallucinogenic effects of lysergic acid diethylamide (LSD) have been attributed primarily to actions at serotonin receptors. A number of studies conducted in the 1970s indicated that LSD also has activity at dopamine (DA) receptors. These latter studies are difficult to interpret, however, because they were completed before the recognition of two pharmacologically distinct DA receptor...